World Health Organization Issues Warning Over Severe Scarcity of Obesity Jabs

Less than one in 10 patients that would benefit from weight-loss injections including Wegovy are able to get them, warns the global health agency as it releases its initial guidance on the medications.

Considering in excess of 1,000,000,000 individuals worldwide now living with obesity, it is advocating for increased and just availability to these injectable treatments.

According to projections, more than two billion will be obese by 2030 unless action is taken.

"The latest guidelines recognises that obesity is a chronic disease that can be managed with holistic and lifelong treatment," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and distribution challenges are major obstacles to broad availability to the jabs that can aid individuals in losing considerable weight, says the agency.

GLP-1 Therapy Shortage

Despite the current most optimistic scenario, the manufacturing of GLP-1 therapies might only reach approximately 100 million people – less than 10% of eligible patients, per the WHO.

The guideline urges nations and manufacturers to expand availability, through strategies including patent sharing.

Exclusive production rights on a key compound – the core ingredient of the drug Wegovy – is scheduled to end in a number of nations in 2026.

The Way Obesity Jabs Function

GLP-1 drugs replicate a body's own hormone to delay gastric emptying, reduce hunger and enhance feelings of fullness so users eat less.

Patients typically start to lose weight after several weeks of commencing the regular doses.

Studies suggests users may regain a significant portion a year later of stopping the medication, as their usual food cravings return.

Being above a healthy weight increases your risk for experiencing medical conditions, such as type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.

Obesity impacts people in countries worldwide and was responsible for 3.7 million deaths worldwide in 2024, as per the WHO.